Literature DB >> 20576042

Hybrid procedures: adverse events and procedural characteristics--results of a multi-institutional registry.

Ralf Holzer1, Audrey Marshall, Jackie Kreutzer, Russel Hirsch, Joanne Chisolm, Sharon Hill, Mark Galantowicz, Alistair Phillips, John Cheatham, Lisa Bergerson.   

Abstract

INTRODUCTION: Procedural cooperation between cardiac surgeon and interventional cardiologist to facilitate interventions such as device delivery or angioplasty (hybrid procedure) has become increasingly common in the management of patients with congenital heart disease.
DESIGN: Data were prospectively collected using a multicenter registry (C3PO). Between February 2007 and December 2008, seven institutions submitted data regarding 7019 cardiac catheterization procedures. Procedural data and adverse events (AEs) of 128 hybrid procedures were evaluated.
RESULTS: There was significant variability in the number of hybrid procedures per center, ranging from one to 89 with a median of eight. A total of 60% of interventional (vs. strictly diagnostic) hybrid procedures were performed by one center. The median weight was 3.7 kg (0.7-86 kg). Single-ventricle circulation was present in 60% of the procedures. Hybrid procedures included: patent ductus arteriosus (PDA) stent placement (n = 55), vascular rehabilitation (n = 25), ventricular septal defect (VSD) device closure (n = 7), valvotomy (n = 3), and diagnostic hybrid procedures (n = 38). Sixteen AEs occurred in 15/128 (12%) procedures. These included minor or trivial AEs (n = 9), moderate AEs (n = 5), major AEs (n = 1), and catastrophic AEs (n = 1). The type of AE documented included arrhythmias (n = 6), hypoxia or hypotension (n = 3), vessel or cardiac trauma (n = 2), and other events (n = 5). Of documented AEs, 9/16 (56%) were classified as not preventable, 6/16 (38%) as possibly preventable, and 1/16 (6%) as preventable. The incidence of AE related to PDA stent placement with surgical exposure (5/50, 10%) was significantly lower when compared with PDA stent placement performed percutaneously (4/5, 80%, P= .002).
CONCLUSION: Hybrid procedures appear to have a low incidence of associated major AEs. PDA stent placement performed as a palliation of hypoplastic left heart syndrome (HLHS) or complex single/two ventricle patients may have a lower incidence of AEs if performed using a direct approach with surgical exposure rather than a percutaneous approach. Accurate definitions of these innovative procedures are required to facilitate prospective data collection.

Entities:  

Mesh:

Year:  2010        PMID: 20576042     DOI: 10.1111/j.1747-0803.2010.00416.x

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  8 in total

Review 1.  Utilizing Hybrid Techniques to Maximize Clinical Outcomes in Congenital Heart Disease.

Authors:  David W Bearl; Gregory A Fleming
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

2.  Developing tools to measure quality in congenital catheterization and interventions: the congenital cardiac catheterization project on outcomes (C3PO).

Authors:  Nadia Chaudhry-Waterman; Sandra Coombs; Diego Porras; Ralf Holzer; Lisa Bergersen
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Apr-Jun

3.  Staged treatment of a premature newborn with interrupted aortic arch and aorta-pulmonary window using intraoperative hybrid procedure before subsequent total correction - Long-term follow-up.

Authors:  Piotr Weryński; Agnieszka Malinowska-Weryńska; Agnieszka Wójcik; Jacek Kołcz
Journal:  Ann Pediatr Cardiol       Date:  2022-08-19

4.  Transverse Sternal Split: a Safe Mini-invasive Approach for Perventricular Device Closure of Ventricular Septal Defect.

Authors:  Pankaj Garg; Arvind Kumar Bishnoi; Ketav Lakhia; Jigar Surti; Sumbul Siddiqui; Parth Solanki; Himani Pandya
Journal:  Braz J Cardiovasc Surg       Date:  2017 May-Jun

5.  Incidence and management of life-threatening adverse events during cardiac catheterization for congenital heart disease.

Authors:  C Huie Lin; Sanjeet Hegde; Audrey C Marshall; Diego Porras; Kimberlee Gauvreau; David T Balzer; Robert H Beekman; Alejandro Torres; Julie A Vincent; John W Moore; Ralf Holzer; Laurie Armsby; Lisa Bergersen
Journal:  Pediatr Cardiol       Date:  2013-07-31       Impact factor: 1.655

Review 6.  The Future of Paediatric Heart Interventions: Where Will We Be in 2030?

Authors:  Tomohito Kogure; Shakeel A Qureshi
Journal:  Curr Cardiol Rep       Date:  2020-10-09       Impact factor: 2.931

7.  Hybrid approach for closure of muscular ventricular septal defects.

Authors:  Ireneusz Haponiuk; Maciej Chojnicki; Radoslaw Jaworski; Mariusz Steffek; Jacek Juscinski; Mariusz Sroka; Roland Fiszer; Aneta Sendrowska; Katarzyna Gierat-Haponiuk; Bohdan Maruszewski
Journal:  Med Sci Monit       Date:  2013-07-29

8.  Alternative hybrid and staged interventional treatment of congenital heart defects in critically ill children with complex and non-cardiac problems.

Authors:  Ireneusz Haponiuk; Maciej Chojnicki; Radosław Jaworski; Mariusz Steffens; Aneta Szofer-Sendrowska; Konrad Paczkowski; Ewelina Kwaśniak; Jacek Zieliński; Katarzyna Gierat-Haponiuk; Katarzyna Leszczyńska
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2015-02-25       Impact factor: 1.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.